메뉴 건너뛰기




Volumn 127, Issue 5, 2014, Pages 633-643

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

Author keywords

Apolipoprotein E; Cerebrospinal fluid; Isoform; Mass spectrometry; Plasma

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; TAU PROTEIN; THREONINE; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT;

EID: 84899898187     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1266-2     Document Type: Article
Times cited : (120)

References (51)
  • 3
    • 79959772357 scopus 로고    scopus 로고
    • Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance
    • doi:10.1126/scitranslmed.3002156
    • Castellano JM, Kim J, Stewart FR et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57. doi:10.1126/scitranslmed.3002156
    • (2011) Sci Transl Med , vol.3
    • Castellano, J.M.1    Kim, J.2    Stewart, F.R.3
  • 5
    • 84862777666 scopus 로고    scopus 로고
    • ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models
    • doi:10.1126/science.1217697
    • Cramer PE, Cirrito JR, Wesson DW et al (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503-1506. doi:10.1126/science.1217697
    • (2012) Science , vol.335 , pp. 1503-1506
    • Cramer, P.E.1    Cirrito, J.R.2    Wesson, D.W.3
  • 6
    • 84867119124 scopus 로고    scopus 로고
    • Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease
    • doi:10.1093/hmg/dds296
    • Cruchaga C, Kauwe JS, Nowotny P et al (2012) Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet 21:4558-4571. doi:10.1093/hmg/dds296
    • (2012) Hum Mol Genet , vol.21 , pp. 4558-4571
    • Cruchaga, C.1    Kauwe, J.S.2    Nowotny, P.3
  • 7
    • 80053646543 scopus 로고    scopus 로고
    • Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
    • doi:10.1016/j.neurobiolaging.2010.04.028
    • Darreh-Shori T, Forsberg A, Modiri N et al (2011) Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging 32(2320):e2315-e2332. doi:10.1016/j.neurobiolaging.2010.04.028
    • (2011) Neurobiol Aging , vol.32 , Issue.2320
    • Darreh-Shori, T.1    Forsberg, A.2    Modiri, N.3
  • 11
    • 79953193799 scopus 로고    scopus 로고
    • Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging
    • doi:10.1212/WNL.0b013e318211c352
    • Gupta VB, Laws SM, Villemagne VL et al (2011) Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76:1091-1098. doi:10.1212/WNL.0b013e318211c352
    • (2011) Neurology , vol.76 , pp. 1091-1098
    • Gupta, V.B.1    Laws, S.M.2    Villemagne, V.L.3
  • 12
    • 33746311471 scopus 로고    scopus 로고
    • Apolipoprotein E structure: Insights into function
    • DOI 10.1016/j.tibs.2006.06.008, PII S0968000406001708
    • Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31:445-454. doi:10.1016/j.tibs.2006.06.008 (Pubitemid 44108662)
    • (2006) Trends in Biochemical Sciences , vol.31 , Issue.8 , pp. 445-454
    • Hatters, D.M.1    Peters-Libeu, C.A.2    Weisgraber, K.H.3
  • 13
    • 58549109632 scopus 로고    scopus 로고
    • Plasma lipoproteins: Genetic influences and clinical implications
    • doi:10.1038/nrg2481
    • Hegele RA (2009) Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 10:109-121. doi:10.1038/nrg2481
    • (2009) Nat Rev Genet , vol.10 , pp. 109-121
    • Hegele, R.A.1
  • 14
    • 0025257612 scopus 로고
    • Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
    • Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548 (Pubitemid 20107994)
    • (1990) Journal of Lipid Research , vol.31 , Issue.3 , pp. 545-548
    • Hixson, J.E.1    Vernier, D.T.2
  • 15
    • 84890365334 scopus 로고    scopus 로고
    • Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain
    • doi:10.1126/scitranslmed.3007000
    • Hudry E, Dashkoff J, Roe AD et al (2013) Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med 5:212ra161. doi:10.1126/ scitranslmed.3007000
    • (2013) Sci Transl Med , vol.5
    • Hudry, E.1    Dashkoff, J.2    Roe, A.D.3
  • 16
    • 67650094927 scopus 로고    scopus 로고
    • Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age
    • doi:10.1002/ana.21696
    • Kok E, Haikonen S, Luoto T et al (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657. doi:10.1002/ana.21696
    • (2009) Ann Neurol , vol.65 , pp. 650-657
    • Kok, E.1    Haikonen, S.2    Luoto, T.3
  • 17
    • 84878816554 scopus 로고    scopus 로고
    • Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
    • doi:10.1186/1750-1326-8-18
    • LaClair KD, Manaye KF, Lee DL et al (2013) Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener 8:18. doi:10.1186/1750-1326-8-18
    • (2013) Mol Neurodegener , vol.8 , pp. 18
    • LaClair, K.D.1    Manaye, K.F.2    Lee, D.L.3
  • 19
    • 0025878638 scopus 로고
    • Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
    • doi:10.1172/JCI115288
    • Linton MF, Gish R, Hubl ST et al (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88:270-281. doi:10.1172/JCI115288
    • (1991) J Clin Invest , vol.88 , pp. 270-281
    • Linton, M.F.1    Gish, R.2    Hubl, S.T.3
  • 20
    • 84873722367 scopus 로고    scopus 로고
    • Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy
    • doi:10.1038/nrneurol.2012.263
    • Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106-118. doi:10.1038/nrneurol.2012.263
    • (2013) Nat Rev Neurol , vol.9 , pp. 106-118
    • Liu, C.C.1    Kanekiyo, T.2    Xu, H.3    Bu, G.4
  • 21
    • 84868352782 scopus 로고    scopus 로고
    • Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice
    • doi:10.1152/ajpregu.00219.2012
    • Liu M, Kuhel DG, Shen L, Hui DY, Woods SC (2012) Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol 303:R903-R908. doi:10.1152/ajpregu.00219.2012
    • (2012) Am J Physiol Regul Integr Comp Physiol , vol.303
    • Liu, M.1    Kuhel, D.G.2    Shen, L.3    Hui, D.Y.4    Woods, S.C.5
  • 22
    • 84876894324 scopus 로고    scopus 로고
    • Binding of apolipoprotein E inhibits the oligomer growth of amyloid-beta peptide in solution as determined by fluorescence cross-correlation spectroscopy
    • doi:10.1074/jbc.M112.411900
    • Ly S, Altman R, Petrlova J et al (2013) Binding of apolipoprotein E inhibits the oligomer growth of amyloid-beta peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem 288:11628-11635. doi:10.1074/jbc.M112.411900
    • (2013) J Biol Chem , vol.288 , pp. 11628-11635
    • Ly, S.1    Altman, R.2    Petrlova, J.3
  • 23
    • 0034575124 scopus 로고    scopus 로고
    • Apolipoprotein E: Far more than a lipid transport protein
    • doi:10.1146/annurev.genom.1.1.507
    • Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537. doi:10.1146/annurev. genom.1.1.507
    • (2000) Annu Rev Genomics Hum Genet , vol.1 , pp. 507-537
    • Mahley, R.W.1    Rall Jr., S.C.2
  • 24
    • 66349085616 scopus 로고    scopus 로고
    • Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
    • doi:10.1194/jlr.R800069-JLR200
    • Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl):S183-S188. doi:10.1194/jlr.R800069-JLR200
    • (2009) J Lipid Res , vol.50 , Issue.SUPPL.
    • Mahley, R.W.1    Weisgraber, K.H.2    Huang, Y.3
  • 25
    • 84893826356 scopus 로고    scopus 로고
    • Assessment of Peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms
    • doi:10.1021/pr401060x
    • Martinez-Morillo E, Nielsen HM, Batruch I et al (2014) Assessment of Peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. J Proteome Res 13:1077-1087. doi:10.1021/pr401060x
    • (2014) J Proteome Res , vol.13 , pp. 1077-1087
    • Martinez-Morillo, E.1    Nielsen, H.M.2    Batruch, I.3
  • 26
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
    • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 (Pubitemid 14076461)
    • (1984) Neurology , vol.34 , Issue.7 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 28
    • 33745584625 scopus 로고    scopus 로고
    • ApoE plasma levels and risk of cardiovascular mortality in old age
    • doi:10.1371/journal.pmed.0030176
    • Mooijaart SP, Berbee JF, van Heemst D et al (2006) ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 3: e176. doi:10.1371/journal.pmed.0030176
    • (2006) PLoS Med , vol.3
    • Mooijaart, S.P.1    Berbee, J.F.2    Van Heemst, D.3
  • 29
    • 84893736391 scopus 로고    scopus 로고
    • Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro
    • doi:10.1002/glia.22619
    • Mulder SD, Nielsen HM, Blankenstein MA, Eikelenboom P, Veerhuis R (2014) Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 62:493-503. doi:10.1002/glia.22619
    • (2014) Glia , vol.62 , pp. 493-503
    • Mulder, S.D.1    Nielsen, H.M.2    Blankenstein, M.A.3    Eikelenboom, P.4    Veerhuis, R.5
  • 30
    • 77954375412 scopus 로고    scopus 로고
    • Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins
    • doi:10.1002/glia.21004
    • Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R (2010) Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 58:1235-1246. doi:10.1002/glia.21004
    • (2010) Glia , vol.58 , pp. 1235-1246
    • Nielsen, H.M.1    Mulder, S.D.2    Belien, J.A.3    Musters, R.J.4    Eikelenboom, P.5    Veerhuis, R.6
  • 31
    • 58149251844 scopus 로고    scopus 로고
    • Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels
    • Riddell DR, Zhou H, Atchison K et al (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28:11445-11453
    • (2008) J Neurosci , vol.28 , pp. 11445-11453
    • Riddell, D.R.1    Zhou, H.2    Atchison, K.3
  • 32
    • 84879083786 scopus 로고    scopus 로고
    • Fluid biomarkers in Alzheimer's disease-current concepts
    • doi:10.1186/1750-1326-8-20
    • Rosen C, Hansson O, Blennow K, Zetterberg H (2013) Fluid biomarkers in Alzheimer's disease-current concepts. Mol Neurodegener 8:20. doi:10.1186/1750-1326-8-20
    • (2013) Mol Neurodegener , vol.8 , pp. 20
    • Rosen, C.1    Hansson, O.2    Blennow, K.3    Zetterberg, H.4
  • 33
    • 0028026587 scopus 로고
    • Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3
    • doi:10.1172/JCI117407
    • Sanan DA, Weisgraber KH, Russell SJ et al (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94:860-869. doi:10.1172/JCI117407
    • (1994) J Clin Invest , vol.94 , pp. 860-869
    • Sanan, D.A.1    Weisgraber, K.H.2    Russell, S.J.3
  • 34
    • 84896705296 scopus 로고    scopus 로고
    • Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease
    • doi:10.1177/1533317513505133
    • Schmidt C, Becker H, Zerr I (2014) Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease. Am J Alzheimers Dis Other Demen 29:54-60. doi:10.1177/1533317513505133
    • (2014) Am J Alzheimers Dis Other Demen , vol.29 , pp. 54-60
    • Schmidt, C.1    Becker, H.2    Zerr, I.3
  • 35
    • 84876672025 scopus 로고    scopus 로고
    • Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: Potential mechanisms underlying regional vulnerability to amyloid-beta accumulation
    • doi:10.1007/s00401-013-1086-9
    • Shinohara M, Petersen RC, Dickson DW, Bu G (2013) Brain regional correlation of amyloid-beta with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-beta accumulation. Acta Neuropathol 125:535-547. doi:10.1007/s00401-013- 1086-9
    • (2013) Acta Neuropathol , vol.125 , pp. 535-547
    • Shinohara, M.1    Petersen, R.C.2    Dickson, D.W.3    Bu, G.4
  • 36
    • 84869217993 scopus 로고    scopus 로고
    • Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n = 669): A pilot assay for methionine-containing proteotypic peptides
    • doi:10.1074/mcp.M112.018861
    • Simon R, Girod M, Fonbonne C et al (2012) Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n = 669): a pilot assay for methionine-containing proteotypic peptides. Mol Cell Proteomics 11:1389-1403. doi:10.1074/mcp.M112.018861
    • (2012) Mol Cell Proteomics , vol.11 , pp. 1389-1403
    • Simon, R.1    Girod, M.2    Fonbonne, C.3
  • 37
    • 10044243556 scopus 로고    scopus 로고
    • Apolipoprotein E and cognitive performance: A meta-analysis
    • DOI 10.1037/0882-7974.19.4.592
    • Small BJ, Rosnick CB, Fratiglioni L, Backman L (2004) Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 19:592-600. doi:10.1037/0882-7974.19.4.592 (Pubitemid 39603405)
    • (2004) Psychology and Aging , vol.19 , Issue.4 , pp. 592-600
    • Small, B.J.1    Rosnick, C.B.2    Fratiglioni, L.3    Backman, L.4
  • 38
    • 0023775474 scopus 로고
    • Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels
    • Smit M, de Knijff P, Rosseneu M et al (1988) Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 80:287-292
    • (1988) Hum Genet , vol.80 , pp. 287-292
    • Smit, M.1    De Knijff, P.2    Rosseneu, M.3
  • 39
    • 84862174192 scopus 로고    scopus 로고
    • Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
    • doi:10.1371/journal.pone.0034078
    • Song F, Poljak A, Crawford J et al (2012) Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS ONE 7:e34078. doi:10.1371/journal.pone.0034078
    • (2012) PLoS ONE , vol.7
    • Song, F.1    Poljak, A.2    Crawford, J.3
  • 40
    • 84899905643 scopus 로고    scopus 로고
    • CSF Apo-E levels associate with cognitive decline and MRI changes
    • doi:10.1007/s00401-013-1236-0
    • Toledo JB, Da X, Weiner MW et al (2014) CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol. doi:10.1007/s00401-013- 1236-0
    • (2014) Acta Neuropathol
    • Toledo, J.B.1    Da, X.2    Weiner, M.W.3
  • 41
    • 84874045326 scopus 로고    scopus 로고
    • APOE epsilon4 increases risk for dementia in pure synucleinopathies
    • doi:10.1001/jamaneurol.2013.600
    • Tsuang D, Leverenz JB, Lopez OL et al (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223-228. doi:10.1001/jamaneurol.2013.600
    • (2013) JAMA Neurol , vol.70 , pp. 223-228
    • Tsuang, D.1    Leverenz, J.B.2    Lopez, O.L.3
  • 42
    • 77953248905 scopus 로고    scopus 로고
    • Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
    • doi:10.1016/j.bbalip.2010.02.007
    • Vance JE, Hayashi H (2010) Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 1801:806-818. doi:10.1016/j.bbalip.2010.02.007
    • (2010) Biochim Biophys Acta , vol.1801 , pp. 806-818
    • Vance, J.E.1    Hayashi, H.2
  • 43
    • 0033637408 scopus 로고    scopus 로고
    • Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
    • Vanderstichele H, Van Kerschaver E, Hesse C et al (2000) Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 7:245-258
    • (2000) Amyloid , vol.7 , pp. 245-258
    • Vanderstichele, H.1    Van Kerschaver, E.2    Hesse, C.3
  • 44
    • 0034607960 scopus 로고    scopus 로고
    • Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization
    • DOI 10.1016/S0304-3940(00)01036-3, PII S0304394000010363
    • Vanmechelen E, Vanderstichele H, Davidsson P et al (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285:49-52. doi:10.1016/S0304-3940(00)01036-3 (Pubitemid 30224621)
    • (2000) Neuroscience Letters , vol.285 , Issue.1 , pp. 49-52
    • Vanmechelen, E.1    Vanderstichele, H.2    Davidsson, P.3    Van Kerschaver, E.4    Van Der, P.B.5    Sjogren, M.6    Andreasen, N.7    Blennow, K.8
  • 46
    • 79951713725 scopus 로고    scopus 로고
    • Apolipoprotein E in Alzheimer's disease and other neurological disorders
    • doi:10.1016/S1474-4422(10)70325-2
    • Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10:241-252. doi:10.1016/S1474-4422(10)70325-2
    • (2011) Lancet Neurol , vol.10 , pp. 241-252
    • Verghese, P.B.1    Castellano, J.M.2    Holtzman, D.M.3
  • 47
    • 84877326649 scopus 로고    scopus 로고
    • ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions
    • doi:10.1073/pnas.1220484110
    • Verghese PB, Castellano JM, Garai K et al (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci USA 110:E1807-E1816. doi:10.1073/pnas.1220484110
    • (2013) Proc Natl Acad Sci USA , vol.110
    • Verghese, P.B.1    Castellano, J.M.2    Garai, K.3
  • 48
    • 83455230813 scopus 로고    scopus 로고
    • Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: A systematic review and meta-analysis
    • doi:10.1159/000334607
    • Ward A, Crean S, Mercaldi CJ et al (2012) Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 38:1-17. doi:10.1159/000334607
    • (2012) Neuroepidemiology , vol.38 , pp. 1-17
    • Ward, A.1    Crean, S.2    Mercaldi, C.J.3
  • 49
    • 84872189834 scopus 로고    scopus 로고
    • Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy
    • doi:10.1371/journal.pone.0053250
    • Wennstrom M, Surova Y, Hall S et al (2013) Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS ONE 8:e53250. doi:10.1371/journal.pone.0053250
    • (2013) PLoS ONE , vol.8
    • Wennstrom, M.1    Surova, Y.2    Hall, S.3
  • 50
    • 84861896052 scopus 로고    scopus 로고
    • In vivo human apolipoprotein E isoform fractional turnover rates in the CNS
    • doi:10.1371/journal.pone.0038013
    • Wildsmith KR, Basak JM, Patterson BW et al (2012) In vivo human apolipoprotein E isoform fractional turnover rates in the CNS. PLoS ONE 7:e38013. doi:10.1371/journal.pone.0038013
    • (2012) PLoS ONE , vol.7
    • Wildsmith, K.R.1    Basak, J.M.2    Patterson, B.W.3
  • 51
    • 84876136764 scopus 로고    scopus 로고
    • Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease
    • doi:10.1001/jamaneurol.2013.2152
    • Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 70:440-444. doi:10.1001/ jamaneurol.2013.2152
    • (2013) JAMA Neurol , vol.70 , pp. 440-444
    • Zlokovic, B.V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.